Physician profile
Mary E Lyons
NPI 1487314159
$3,068.94
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,011 · 2023: $1,917 · 2024: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,271 · Travel and Lodging: $650 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,271.18 |
| Travel and Lodging | $649.76 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,590.52 | 2022-2023 | Interstim |
| Astellas Pharma US INC | $253.62 | 2023-2024 | Myrbetriq |
| Progenics Pharmaceuticals, INC. | $159.43 | 2023 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $138.20 | 2022-2023 | |
| Medical Device Business Services, INC. | $137.01 | 2023 | |
| 180 Medical, INC. | $111.84 | 2022-2023 | Gentlecath |
| Myriad Genetic Laboratories, INC. | $95.32 | 2022-2023 | Prolaris |
| Sumitomo Pharma America, INC. | $83.45 | 2023 | Gemtesa |
| Tolmar, INC. | $57.44 | 2023-2024 | |
| Urovant Sciences INC | $53.36 | 2022 | |
| Merck Sharp & Dohme LLC | $50.98 | 2023-2024 | Lynparza, Bridion |
| Tolmar Pharmaceuticals, INC. | $45.70 | 2022 | |
| Abbvie INC. | $38.51 | 2023-2024 | |
| Hollister Incorporated | $36.04 | 2022-2023 | Vapro Pocket |
| Accord Healthcare, INC. | $31.78 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $29.20 | 2023 | Stratafix, Dermabond Prineo |
| Urogen Pharma, INC. | $27.42 | 2023 | Jelmyto |
| Tempus Ai, INC | $25.94 | 2024 | |
| Travere Therapeutics, INC. | $22.71 | 2022 | |
| Janssen Biotech, INC. | $21.24 | 2022 | |
| Laborie Medical Technologies Corp. | $16.97 | 2023 | |
| Axonics, INC. | $16.45 | 2023 | Axonics, Bulkamid |
| Alnylam Pharmaceuticals INC. | $13.26 | 2023 | Oxlumo |
| Antares Pharma, INC. | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.